A tailored course, built for your situation
Audit-Tested AI in Pharmaceutical R&D Operations for Senior Leaders
Implement AI with confidence, compliance, and measurable impact
The situation this course is for
Senior leaders in pharmaceutical R&D face increasing pressure to deliver innovation faster while maintaining strict compliance. Early AI pilots often fail to scale because they lack documentation, validation, or alignment with GxP and regulatory expectations. This creates friction between data science teams and quality assurance, slowing progress and weakening trust.
Who this is for
Senior R&D, operations, and technology leaders in pharmaceutical and life sciences organizations responsible for delivering compliant, innovative products at speed.
Who this is not for
Individual contributors without decision-making authority in R&D or operations; those seeking theoretical AI overviews or non-regulated industry applications.
What you walk away with
- Deploy AI models with embedded audit readiness from design through validation
- Align AI initiatives with regulatory frameworks including FDA and EMA expectations
- Reduce time-to-approval for AI-augmented drug development cycles
- Lead cross-functional teams with clarity on compliance, data lineage, and model governance
- Build internal trust and secure buy-in from quality, legal, and executive stakeholders
The 12 modules (with all 144 chapters)
- Defining audit-tested AI
- Regulatory landscape overview
- Key differences from general AI deployment
- GxP implications for machine learning
- Role of data integrity in model validation
- Establishing accountability frameworks
- Documenting AI lifecycle stages
- Risk-based classification of AI tools
- Aligning with internal QA standards
- Building cross-functional governance
- Common pitfalls in early adoption
- Case study: AI in preclinical decisioning
- FDA AI/ML guidance interpretation
- EMA position on algorithmic transparency
- ICH considerations for adaptive models
- Preparing for inspection readiness
- Audit trail requirements for AI systems
- Defining model oversight roles
- Submission strategies for AI-enhanced workflows
- Change control for model updates
- Version control of training data
- Handling model drift in regulated settings
- Third-party vendor validation
- Case study: AI in clinical trial design
- Principles of data lineage
- Metadata tagging for AI pipelines
- Establishing immutable logs
- Data curation under ALCOA+
- Versioning datasets and transformations
- Automated lineage tracking tools
- Human-in-the-loop documentation
- Audit trails for data cleaning steps
- Handling missing or corrupted data
- Cross-system data flow mapping
- Role of metadata in inspection
- Case study: AI in analytical method development
- Phases of model validation
- Establishing performance benchmarks
- Defining success criteria upfront
- Testing for bias and fairness
- Validation under real-world conditions
- Establishing revalidation triggers
- Documentation for model versioning
- Handling model decay over time
- Retraining process governance
- Version control for AI artifacts
- Model retirement protocols
- Case study: AI in formulation optimization
- AI governance committee design
- Roles and responsibilities matrix
- Escalation paths for model issues
- Periodic review cycles
- Risk-based tiering of AI applications
- Internal audit preparedness
- Cross-functional alignment strategies
- Training requirements for stakeholders
- Model inventory management
- Change control for AI components
- Vendor oversight integration
- Case study: AI in stability prediction
- Defining change scope for AI systems
- Assessing impact on validation status
- Deviation reporting for model anomalies
- Root cause analysis for AI failures
- Corrective and preventive actions (CAPA)
- Version rollback strategies
- Documentation of change rationale
- Approval workflows for updates
- Handling unplanned model behavior
- Audit readiness for change logs
- Post-deployment monitoring
- Case study: AI in impurity profiling
- Designing for human oversight
- Defining decision thresholds
- Role clarity in hybrid workflows
- Training for AI-assisted decisions
- Audit trails for human overrides
- Escalation protocols
- Bias detection by human reviewers
- Feedback loops for model improvement
- Documentation of rationale
- Compliance with ALCOA+ for decisions
- Workload considerations
- Case study: AI in clinical data review
- AI for patient stratification
- Predictive enrollment modeling
- Risk-based monitoring with AI
- Adaptive trial design support
- Data safety monitoring boards
- Regulatory expectations for AI in trials
- Validation of clinical AI models
- Handling protocol deviations
- Ethical considerations
- Documentation for IRB submissions
- Vendor validation for CROs
- Case study: AI in dose selection
- AI for real-time release testing
- Predictive maintenance models
- Anomaly detection in production
- Process optimization with ML
- Validation under GMP
- Change control for AI in manufacturing
- Audit readiness for shop floor AI
- Integration with MES and SCADA
- Handling batch-level decisions
- Model explainability for operators
- Training for plant teams
- Case study: AI in tablet dissolution prediction
- Assessing vendor maturity
- Contractual requirements for AI
- Audit rights and transparency
- Validation of third-party models
- Data ownership and IP
- Security and access controls
- Performance monitoring of vendors
- Exit strategies
- Due diligence checklists
- Handling vendor model updates
- Regulatory inspection of vendor systems
- Case study: AI in CRO-partnered trials
- Stakeholder alignment roadmap
- Phased rollout strategies
- Pilot project design
- Scaling from proof of concept
- Change management for AI adoption
- Training programs for diverse roles
- KPIs for AI performance
- Feedback collection mechanisms
- Budgeting for AI lifecycle
- Resource allocation models
- Success metrics beyond accuracy
- Case study: AI in global regulatory submissions
- Continuous monitoring frameworks
- Periodic revalidation schedules
- Internal audit integration
- Regulatory intelligence updates
- AI maturity assessment
- Knowledge transfer protocols
- Succession planning for AI roles
- Lessons from inspection outcomes
- Building AI centers of excellence
- Benchmarking against peers
- Future-proofing AI strategy
- Final capstone: building your implementation plan
How this maps to your situation
- Leading AI adoption in a regulated R&D environment
- Scaling AI beyond pilot stages with compliance
- Preparing for regulatory scrutiny of AI systems
- Aligning cross-functional teams on AI governance
Before vs. after
What's included with your purchase
- 12 modules with 12 chapters each (144 chapters)
- Downloadable templates and worked examples for every module
- Hand-built implementation playbook delivered alongside course access
- 30-day money-back guarantee
Delivery and format
- Course and learning environment access provisioned within 24 hours of purchase
- Hand-built implementation playbook delivered alongside course access
Format: Text-based modules and chapters in the Art of Service learning environment, plus downloadable templates and worked examples for every chapter, plus the hand-built implementation playbook delivered alongside course access.
Time investment: Approximately 4 hours per module, designed for senior leaders to complete at their own pace over 8, 12 weeks.
How this compares to the alternatives
Unlike generic AI courses, this program is purpose-built for pharmaceutical R&D, with deep integration of regulatory expectations, GxP principles, and real-world implementation patterns, ensuring practical, inspection-ready outcomes.
Frequently asked
Within 24 hours your account in the learning environment is provisioned and the tailored implementation playbook is delivered alongside it.